Literature DB >> 25371140

Bioinformatic analysis of microRNA expression in Parkinson's disease.

Bin Hao1, Xin Chen1, Dongwei Dai1, Chao Zou1, Xi Wu1, Jianchun Chen1.   

Abstract

Parkinson's disease (PD) is a type of movement disorder caused by loss of dopamine‑producing neurons in the midbrain. In order to identify the synergistic microRNA (miRNA) pattern in PD, miRNA and mRNA double expression profiles of PD were downloaded. Differentially expressed miRNA and mRNA were identified [P<0.01, following false discovery rate (FDR) correction]. A cumulative hypergeometric distribution test was then performed to identify synergistic miRNAs (P<0.01, following FDR correction). Gene ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations were performed to analyze the miRNA regulatory target genes. Subsequently, a synergistic miRNA network was constructed and miRNAs exhibiting a high degree were identified. In total, 200 differentially expressed miRNA and 2,966 differentially expressed mRNA were identified. In addition, 1,502 synergistic miRNA interactions were identified, and miRNAs regulated 304 target genes in total. The GO and KEGG analysis demonstrated that these target genes were enriched in biosynthetic and cellular biosynthetic processes, the assembly of cellular components in morphogenesis, mitogen‑activated protein kinase signaling, myometrial relaxation and contraction pathways as well as calcium regulation. The miRNA network demonstrated that miR‑627, miR‑634, miR‑514, miR‑563 and miR‑613 had a high degree. miRNA with a high degree may be associated with the pathogenesis of PD and, therefore, may assist in the diagnosis and therapy of PD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25371140     DOI: 10.3892/mmr.2014.2837

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

Review 1.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

2.  MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways.

Authors:  Ying Liu; Yanfeng Song; Xiaotun Zhu
Journal:  Med Sci Monit       Date:  2017-04-02

3.  NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.

Authors:  Zirong Fan; Jian Zheng; Yixue Xue; Xiaobai Liu; Di Wang; Chunqing Yang; Jun Ma; Libo Liu; Xuelei Ruan; Zhenhua Wang; Yunhui Liu
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

4.  Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.

Authors:  Marco Sancandi; Pinar Uysal-Onganer; Igor Kraev; Audrey Mercer; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

5.  MiR-563 restrains cell proliferation via targeting LIN28B in human lung cancer.

Authors:  Xuefei Zhang; Mo Li; Ge Sun; Yu Bai; Desheng Lv; Changhong Liu
Journal:  Thorac Cancer       Date:  2019-11-25       Impact factor: 3.500

6.  Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.

Authors:  Qihua Chen; Na Deng; Ke Lu; Qiao Liao; Xiaoyan Long; Deming Gou; Fangfang Bi; Jinxia Zhou
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

7.  Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.

Authors:  Zhi Wen; Jie Zhang; Peng Tang; Ning Tu; Ke Wang; Guangyao Wu
Journal:  Mol Med Rep       Date:  2017-10-26       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.